November 14, 2019
FDA: Class I recall of Zimmer Biomet’s ROSA Brain 3.0 Robotic Surgery System
Editor's Note
The Food & Drug Administration on November 7 identified the recall by Zimmer Biomet of its ROSA Brain 3.0 Robotic Surgery System as Class I, the most serious.
The recall was initiated because of a software issue that incorrectly positions the robotic arm. The company has received five complaints related to this issue, including one patient injury. No deaths have been reported.
Distribution dates for the system were April 8, 2016, to March 19, 2019.
Free Daily News
- Healthcare employment up in November
- Nonprofit hospitals face ongoing struggles in 2024
- ASCs lock in higher Medicare, Medicaid payment rate
- HHS releases concept paper on cybersecurity for healthcare sector
- Study examines infection precautions during pandemic based on healthcare roles
- Postoperative opioid prescriptions falling, but more improvement needed
- New protein calculation uncovers which organs are aging at an accelerated pace
- Researchers are calling for better tracking of chronic diseases
- New Joint Commission certification addresses secondary use of data
- New wearable device system could aid in remote medical monitoring
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging